Conditions: Neuralgia, Postherpetic
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 294
Healthy volunteers: no

Brief summary:
This study will evaluate the safety and efficacy of AGN-214868 in patients with postherpetic neuralgia (PHN) - nerve pain.

Detailed description:

Arms:
arm 1: AGN-214868 injected into areas of postherpetic neuralgia pain for a total dose of 3.25 μg per treatment. arm 2: AGN-214868 injected into areas of postherpetic neuralgia pain for a total dose of 16.25 μg per treatment. arm 3: Placebo to AGN-214868 injected into areas of postherpetic neuralgia pain per treatment.

Interventions: intervention 1: AGN-214868 intervention 2: Placebo to AGN-214868
Intervention descriptions: intervention 1: AGN-214868 injected into areas of postherpetic neuralgia pain for total dose per treatment. intervention 2: Placebo to AGN-214868 injected into areas of postherpetic neuralgia pain per treatment.

Protocol document: